We herewith enclose the declaration required to be disclosed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from the promoters ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis AG, the promoter of Novartis India Ltd, has submitted a declaration under Regulation 31(4) of the SEBI Takeover Regulations, 2011, as of March 31, 2025. The promoter holds 1,74,50,680 equity shares in the company. Novartis AG has confirmed that it has not created any encumbrance (pledge, lien, or charge) on these shares, either directly or indirectly. This is a routine annual/periodic compliance filing required from promoters to disclose the encumbrance status of their holdings.
This is a neutral, compliance-driven disclosure. It simply confirms that the promoter has not pledged any of its shares, which means there is no risk of forced selling or margin calls from the promoter side. No material impact on the stock price is expected.